Furthermore, the expression of three colorectal cancer stem cell markers, CD44, CD66c and CD133, were evaluated (43,44) on CD326+ and CD26+/CD326− cells, observing the consistent expression of CD44 and CD66c along with a substantial negativity for CD133 (data not shown). This evidence concerns the gene CEACAM6 and colorectal cancer.